Jan A. Bruijn, MD, PhD
- 4Articles
- 9.5KReads
- 1998–2006Active
- 5Collaborators
About
Jan A. Bruijn, MD, PhD, has published extensively on the treatment of major depressive disorder (MDD), focusing on clinical strategies for depressed inpatients. The research includes evaluations of pharmacological approaches such as imipramine, tranylcypromine, phenelzine, and lithium, as well as the role of electroconvulsive therapy (ECT) in treatment-resistant cases. Bruijn’s work, appearing between 1998 and 2006, addresses treatment algorithms, relapse prevention, and comparative efficacy and tolerability of antidepressant regimens. Frequent collaborators include Peter Moleman, Walter W. van den Broek, Tom K. Birkenhäger, and Paul G. H. Mulder.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
